Rhenman & Partners Asset Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $1.24M | Hold |
|
|||||
|
2017
Q4 | $1.41M | Sell |
|
|||||
|
2017
Q3 | $2.84M | Sell |
|
|||||
|
2017
Q2 | $3.07M | Hold |
|
|||||
|
2017
Q1 | $2.62M | Hold |
|
|||||
|
2016
Q4 | $2.49M | Sell |
|
|||||
|
2016
Q3 | $2.66M | Buy |
|
|||||
|
2016
Q2 | $2.98M | Sell |
|
|||||
|
2016
Q1 | $4.44M | Sell |
|
|||||
|
2015
Q4 | $6.23M | Sell |
|
|||||
|
2015
Q3 | $5.5M | Buy |
|
|||||
|
2015
Q2 | $5.33M | Buy |
|
|||||
|
2015
Q1 | $3.78M | Buy |
|
|||||
|
2014
Q4 | $1.28M | Sell |
|
|||||
|
2014
Q3 | $1.87M | Sell |
|
|||||
|
2014
Q2 | $3.69M | Sell |
|
|||||
|
2014
Q1 | $4.52M | Sell |
|
|||||
|
2013
Q4 | $5.18M | Buy |
|